Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

about

Structure of the Recombinant Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci

P2860

Q57285397-BACF7BD1-82FA-4F01-B2DC-05921FF6E430

P2860

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

Item

http://www.wikidata.org/entity/Q47117176

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Liposomal vaccine formulations ...... derations for modern vaccines.

@en

Liposomal vaccine formulations ...... derations for modern vaccines.

@nl

type

Item

label

Liposomal vaccine formulations ...... derations for modern vaccines.

@en

Liposomal vaccine formulations ...... derations for modern vaccines.

@nl

prefLabel

Liposomal vaccine formulations ...... derations for modern vaccines.

@en

Liposomal vaccine formulations ...... derations for modern vaccines.

@nl

P1476

Liposomal vaccine formulations ...... derations for modern vaccines.

@en

P2093

David J Burkhart

http://www.w3.org/2001/XMLSchema#string

Luis O De Serrano

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer

World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis

Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis

HIV and mycobacteria.

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis

Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.

Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.

Pseudomonas aeruginosa lipopolysaccharides and pathogenesis.

Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.

P2888

s12951-017-0319-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12951-017-0319-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092751165

http://www.w3.org/2001/XMLSchema#string

P698

29149896

http://www.w3.org/2001/XMLSchema#string

P921

parasitic infectious diseases

viral infectious disease

manufactured product

fungal infectious disease

pharmaceutical preparation

bacterial infectious disease

P932

5693489

http://www.w3.org/2001/XMLSchema#string

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

about

P2860

P2860

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P6179

P698

P921

P932